Research and Markets: Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2014 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rnbhv2/gastrointestinal) has announced the addition of the "Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2014 Update" report to their offering.

The latest report Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Gastro-Intestinal Stromal Tumors market. It covers emerging therapies for Gastro-Intestinal Stromal Tumors in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Gastro-Intestinal Stromal Tumors pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Gastro-Intestinal Stromal Tumors pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Gastro-Intestinal Stromal Tumors pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which Gastro-Intestinal Stromal Tumors pipeline products will be launched in the US and Ex-US till 2017.

SUMMARY:

- Gastro-Intestinal Stromal Tumors phase 3 clinical trial pipeline molecules

- Gastro-Intestinal Stromal Tumors phase 2 clinical trial pipeline molecules

- Gastro-Intestinal Stromal Tumors phase 1 clinical trial pipeline molecules

- Gastro-Intestinal Stromal Tumors preclinical research pipeline molecules

- Gastro-Intestinal Stromal Tumors discovery stage pipeline molecules

- Gastro-Intestinal Stromal Tumors pipeline molecules short-term launch highlights

For more information visit http://www.researchandmarkets.com/research/rnbhv2/gastrointestinal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals